Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $17-Report Released on 4 February 2024
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories (NYSE:CLB) and lowers the price target from $21 to $17 as of 4 February 2024.

February 05, 2024 | 9:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories and lowers the price target from $21 to $17.
The reduction in price target by Stifel from $21 to $17 suggests a bearish outlook on Core Laboratories' stock in the short term. This adjustment reflects the analyst's view on the company's future performance, potentially influencing investor sentiment and leading to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100